Publikācijas » Search Results » 1997

 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962
Rezultātu skaits lapā  
Konferences
51Krauze A.; Ģērmane S.; Kluša V.; Duburs G. Synthesis and neurotropic activity of 3-cyano(carbomoyl)-pyridine-2(1H)-thiones and their derivatives. Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1; Riga, Latvia, Eds.; Pharmacol. Toxicol.: Vol.80, Supp.1, 1997; 31.      

52Kluša V.; Ģērmane S.; Duburs G. Taurine and tauropyrone: anti-neurodeficit activity in alcoholized rats . Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1; Riga, Latvia, Eds.; Pharmacol. Toxicol.: Vol.80, Supp.1, 1997; 29.      

53Ģērmane S.; Dirnēns V.; Pokrovska N.; Lukevics E. Novel antiamnestic compounds in the series of silicon-containing isoxazolines. Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1; Riga, Latvia, Eds.; Pharmacol. Toxicol.: Vol.80, Supp.1, 1997; 23.      

54Duburs G.; Kluša V.; Bisenieks E.; Poikāns J. Amino acid-containing derivatives as novel class of neuroprotectants. Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1: Riga, Latvia, Vol.80, Suppl.1, 1997; 19.      

55Danysz W.; Parsons C.G.; Karcz-Kubicha M.; Hesselink M.; Wenk G.L.; Lazarewicz J.; Popik P.; Gold M.; Kalvinsh I.; Piskunova I.; Rozhkov E. Novel systemically-active antagonists of the glycine site of NMDA receptor - neuroprotective effects and behavioural characterisation . Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1; Riga, Latvia, Eds.; Pharmacol. Toxicol.: Vol.80, Supp.1, 1997; 17.      

56Polevaya L.; Matsoukas J.; Vlahakos D.; Mutule I.; Mutule I. Angiotensin-like fragments of thrombin: synthesis and bioscreening . Lecture progr. a. abstr. book, Fifth International Symposium Solid phase synthesis. Combinatorial chemical libraries: Complementary solution methods biological and biomedical applications; 2nd-6th Sept.: Venue, London, England, UK, LP25, 1997.      

57Liepina I.; Blanco M.; Reissmann S. Conformational analysis of cyclic bradykinin antagonist. Progr. a. abstr., Fifteenth American peptide symp.; June 14-19: Nashville, Tennessee, 1997; 2.      

58Ozola V.; Maurinsh Y.; Lidaka M. Synthesis of derivatives of 3-methylxanthine and 1-methyl-3-isobutylxanthine 7-beta-D-ribofuranosides . Dedicated to the 60th birthdays of prof. H.Selinger & J.H.van Boom and the 70th birthday of prof. W.Pfleiderer, Nucleic acids and related macromolecules: synthesis, structure, function and applications. ; Sept. 4-9: Ulm, Germany, P28, 1997.      

59Alksnis E.; Korņejeva D.; Vītoliņa R.; Lukevics E. Silizium-haltige xanthinderivate und ihre kardiovaskulare aktivitat. 6.Nachwuchswissenschaftler-Symp. Bioorganische Chemie ; 22-24. Sept.: Paderborn, Germany, 1997.      

Scopus datu bāzē indeksētās publikācijas
60Gyurcsik B.; Vosekalna I.; *Larsen E. Copper(II) complexes of oligopeptides. An equilibrium and spectroscopic study on the copper(II) lys-leu-ala-his-phe-gly system. Acta Chem. Scand. 1997, 51(1), 49-58.      

Rezultātu skaits lapā